Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model. (2017)
Attributed to:
Tropical Infectious Disease Consortium: Sustaining, Expanding and Accelerating Product Development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-017-0029-1
PubMed Identifier: 29263883
Publication URI: http://europepmc.org/abstract/MED/29263883
Type: Journal Article/Review
Volume: 2
Parent Publication: NPJ vaccines
ISSN: 2059-0105